Suppr超能文献

抗精神病药物的非神经安定异构体在抗镰状化治疗中的可能用途。

Possible use of non-neuroleptic isomers of anti-psychotics in anti-sickling therapy.

作者信息

Ohnishi S T, Devlin M T, Sato T, Hashimoto K, Singer M

出版信息

Eur J Pharmacol. 1981 Oct 22;75(2-3):121-5. doi: 10.1016/0014-2999(81)90070-4.

Abstract

Non-neuroleptic isomers and derivatives of three types of anti-psychotic drugs (phenothiazine, thioxanthene and benzocycloheptapyridoisoquinoline) were found to have in vitro anti-sickling activity. The anti-sickling activity of non-neuroleptic isomers is of the same magnitude as that of the anti-psychotic forms. The degree of the suppression of sickling ranged from 40-60% at a concentration of 200 microM. For these drugs, a significant correlation was found between the anti-sickling activity and the inhibition of calmodulin-stimulated phosphodiesterase activity. A possibility is raised that deoxy hemoglobin S polymerization is influenced by membrane-linked mechanisms.

摘要

三种抗精神病药物(吩噻嗪、硫杂蒽和苯并环庚并吡啶异喹啉)的非抗精神病异构体及衍生物被发现具有体外抗镰变活性。非抗精神病异构体的抗镰变活性与抗精神病形式的活性相当。在200微摩尔浓度下,镰变抑制程度为40%-60%。对于这些药物,发现抗镰变活性与钙调蛋白刺激的磷酸二酯酶活性抑制之间存在显著相关性。这就提出了一种可能性,即脱氧血红蛋白S聚合受到膜相关机制的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验